Success Metrics

Clinical Success Rate

75.0%

Based on 6 completed trials

Completion Rate

75%(6/8)

Active Trials

0(0%)

Results Posted

17%(1 trials)

Terminated

2(15%)

Phase Distribution

Ph not_applicable

23%

Ph phase_1

15%

Ph phase_2

23%

Ph phase_3

15%

Ph phase_4

23%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 1Safety & dosage

2(15.4%)

Phase 2Efficacy & side effects

3(23.1%)

Phase 3Large-scale testing

2(15.4%)

Phase 4Post-market surveillance

3(23.1%)

N/ANon-phased studies

3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

54.5%

6 of 11 finished

Non-Completion Rate

45.5%

5 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(5)

Other(2)

Detailed Status

Completed6

Withdrawn3

unknown2

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (15.4%)

Phase 23 (23.1%)

Phase 32 (15.4%)

Phase 43 (23.1%)

N/A3 (23.1%)

Trials by Status

completed646%

unknown215%

withdrawn323%

terminated215%

Recent Activity

0 active trials

Showing 5 of 13

completednot_applicable

Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit

NCT06109740

terminatedphase_2

Clinical Trials (13)

Showing 13 of 13 trials

NCT06109740Not Applicable

Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit

Completed

NCT02719405Phase 2

Impact of Infant Formula on Resolution of Cow's Milk Allergy

Terminated

NCT02185092Not Applicable

Probiotic Use in Patients With Prior COPD Exacerbation

Withdrawn

NCT00304863Phase 4

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Withdrawn

NCT00895336Phase 2

Lactobacillus GG in Pediatric Ulcerative Colitis (UC)

Withdrawn

NCT01130792Phase 1

Probiotics for Infectious Diarrhea in Children in South India

Completed

NCT01657032Phase 4

Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis

Completed

NCT02062476Phase 2

Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy

Unknown

NCT00992290Phase 1

Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy

Completed

NCT01782118Phase 4

LGG for Prevention of Infectious Complications During PPI Treatment in Children

Unknown

NCT01251783Phase 3

A Prebiotic Agave Derivated Metlin & Metlos in Infant Formula

Completed

NCT00613795Phase 3

Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia

Completed

NCT00220519Not Applicable

Lactobacillus GG Supplementation During Pediatric Burn Injuries

Terminated

All 13 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 13